反応 #48368

ord-07e2c95b9113410dad05848fffb4a7be

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他was consumed
  2. 2
    workup.ADDITIONMethanol was added to the reaction
  3. 3
    workup.STIRRINGthe solution stirred for several hours
  4. 4
    その他the solvent was evaporated in vacuo
  5. 5
    workup.DISSOLUTIONThe residue was dissolved in ethyl acetate
  6. 6
    洗浄washed with water and saturated brine
  7. 7
    乾燥dried over magnesium sulfate
  8. 8
    その他The crude product was purified by chromatography (silica gel, 2.5% to 5% methanol in methylene chloride gradient elution), which

実験手順

Carbonyldiimidazole (1.6 g, 9.8 mmol) was added to a solution of 2-amino-3-[(1-t-butoxycarbonylpiperidin-4-yl)amino]-6-methoxypyridine (1.29 g, 4.00 mmol) in acetonitrile (100 mL) at room temperature. The reaction was stirred until all the starting material was consumed. Methanol was added to the reaction and the solution stirred for several hours, then the solvent was evaporated in vacuo. The residue was dissolved in ethyl acetate, washed with water and saturated brine, and then dried over magnesium sulfate. The crude product was purified by chromatography (silica gel, 2.5% to 5% methanol in methylene chloride gradient elution), which gave the title compound. MS 349 (M+1) 1H NMR (500 MHz, CDCl3) δ 8.50 (br s, 1H), 7.29 (d, J=8 Hz, 1H), 6.43 (d, J=8 Hz, 1H), 4.46 (m, 1H), 4.31 (br s, 2H), 3.90 (s, 3H), 2.85 (br s, 2H), 2.13 (m, 2H), 1.85 (d, J=12 Hz, 2H), 1.50 (s, 9H).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07745427B2uspto-grants-2010_06